Executive Snapshot

Figure: European Life Sciences Key IT Deals and Initiatives Update, Q2 2022

Situation Overview

Expanding Pharma Beyond the Pill, Strengthening Patient Engagement

Digital Therapeutics

Smart Drug Delivery Systems

Smart Shopping and Shipping, Pharmacy Omni-Experience

Powering Precision Diagnostics, Expanding Med Tech Innovation and Services

Digital Pathology

Expanding Med Tech Services and Innovation

Expediting R&D and Advancing Precision Medicine

Trusted Research Environments and Collaborative Research Models

AI-Based Drug Discovery and Design

Solutions for Rare Disease Trials

Digital Transformation Toward an Intelligent Life Sciences Enterprise

Accelerating Digital Transformation

Toward Pharma 4.0

Customer Engagement

Supporting Innovation Acceleration

Key Mergers and Acquisitions

Advice for the Technology Buyer

Learn More

Related Research

Synopsis